|

Fed: Limited scope for major cuts in balance sheet – NBC

National Bank of Canada’s Taylor Schleich and Ethan Currie argue that, under current regulations, the Federal Reserve has limited room for major further reductions in its balance sheet, now around $6.5 trillion after prior QT. They highlight that liabilities such as reserves and the Treasury General Account constrain asset shrinkage and expect no restart of QT, only modest tweaks to reinvestment strategy.

Warsh’s stance and QT constraints

"In summary, we view the scope for major further reductions to the Fed’s balance sheet as limited under the current regulatory framework."

"Financial market deregulation—reducing the demand for reserves and allowing banks to absorb the Fed’s Treasuries—would create scope to lessen the FOMC’s portfolio. Still, there are risks when the most stable and predictable buyer/holder of Treasuries is replaced by riskier entities."

"Ultimately, it’s the Fed’s liabilities that drive their assets. Currency demand grows with the economy and the TGA is dictated by the Treasury."

"Without reducing the demand for reserves (chiefly, through regulation), scope for further asset run-off is limited unless the Fed becomes comfortable with greater volatility in funding markets."

"Since QT ended, outright UST buying has all been in T-bills, lowering the duration of the Fed’s portfolio. While we don’t think Warsh will shrink the balance sheet much more, this strategy could be used more (e.g., reinvest UST proceeds in shorter-term debt vs. proportionately on the curve)."

(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)

Author

FXStreet Insights Team

The FXStreet Insights Team is a group of journalists that handpicks selected market observations published by renowned experts. The content includes notes by commercial as well as additional insights by internal and external analysts.

More from FXStreet Insights Team
Share:

Editor's Picks

EUR/USD remains offered below 1.1800, looks at US data

EUR/USD is still trading on the defensive in the latter part of Thursday’s session, while the US Dollar maintains its bid bias as investors now gear up for Friday’s key release of the PCE data, advanced Q4 GDP prints and flash PMIs.
 

GBP/USD bounces off monthly lows near 1.3430

GBP/USD is sliding in tandem with its risk-sensitive peers, drifting back towards the 1.3430 area, its lowest levels in the month. The move reflects a firmer Greenback, supported by another round of solid US data and a somewhat divided FOMC Minutes.

Gold surrenders some gains, back below $5,000

Gold is giving away part of its earlier gains on Thursday, receding to the sub-$5,000 region per troy ounce. The precious metal is finding support from renewed geopolitical tensions in the Middle East and declining US Treasury yields across the curve in a context of further advance in the Greenback.

XRP edges lower as SG-FORGE integrates EUR stablecoin on XRP Ledger

Ripple’s (XRP) outlook remains weak, as headwinds spark declines toward the $1.40 psychological support at the time of writing on Thursday.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.